null

SMILES ONC(=O)c1cnc(NC2(CC2)c2ccccc2)nc1

InChI Key InChIKey=LIIWIMDSZVNYHY-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 139295   

TargetHistone deacetylase 1(Homo sapiens (Human))
REGENACY PHARMACEUTICALS, LLC

US Patent
LigandPNGBDBM139295(US10858323, Compound 1 | US8614223, 73)copy SMILEScopy InChI
Affinity DataIC50: 94nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2W09918US Patent
TargetHistone deacetylase 2(Homo sapiens (Human))
REGENACY PHARMACEUTICALS, LLC

US Patent
LigandPNGBDBM139295(US10858323, Compound 1 | US8614223, 73)copy SMILEScopy InChI
Affinity DataIC50: 128nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2W09918US Patent
TargetHistone deacetylase 3(Homo sapiens (Human))
REGENACY PHARMACEUTICALS, LLC

US Patent
LigandPNGBDBM139295(US10858323, Compound 1 | US8614223, 73)copy SMILEScopy InChI
Affinity DataIC50: 158nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2W09918US Patent
TargetHistone deacetylase 6(Homo sapiens (Human))
REGENACY PHARMACEUTICALS, LLC

US Patent
LigandPNGBDBM139295(US10858323, Compound 1 | US8614223, 73)copy SMILEScopy InChI
Affinity DataIC50: 1.70nMAssay Description:Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2W09918US Patent